This post was updated in 2020 and is part of our SCOPE stem cells not lost in translation project. You can learn more about the project and read the other 34 languages on that page.
What are stem cells?
The human body contains hundreds of different types of cells that are important for our daily health. These cells are responsible for keeping our bodies running each day such as making our hearts beat, brains think, kidneys clean our blood, replace our skin cells as they shed off, and so on. The unique job of stem cells is to make all these other types of cells. They are the suppliers of new cells. When stem cells divide they can make more of themselves or more of other types of cells. For example, stem cells in skin can make more of themselves or they can make differentiated cells of the skin that have specific jobs of their own such as making the melanin pigment.
Why are stem cells important for your health?
When we get injured or sick, our cells also are injured or killed. When this happens, stem cells become active. Stem cells have the job of fixing our injured tissues and of replacing other cells when they routinely die. In this way our stem cells keep us healthy and prevent us from prematurely aging. Stem cells are like our own army of microscopic doctors.
What are the different kinds of stem cells?
Stem cells come in many different forms. Scientists think that every organ of our body has its own specific type of stem cells. For example, our blood is made from blood (also known as hematopoietic) stem cells. However, stem cells are also present from the earliest stages of human development, and when scientists grow these, they are called embryonic stem cells. The reason scientists are excited about embryonic stem cells is that the natural job of embryonic stem cells is to build every organ and tissue in our bodies during human development. What this means is that embryonic stem cells, unlike adult stem cells, can be coaxed into potentially forming almost any other of the hundreds of types of human cells. For example, while a blood stem cell can only make blood, an embryonic stem cell can make blood, bone, skin, brain, and so on. In addition, embryonic stem cells are programmed by nature to build tissues and even organs, while adult stem cells are not. What this means is that embryonic stem cells have a greater natural capacity to fix diseased organs. Embryonic stem cells are made from leftover embryos from fertility treatments that are only a few days old, that were made in a dish in a laboratory, and that would otherwise be thrown away.
What are iPS or induced pluripotent stem cells?
Scientists and doctors are excited about this new type of stem cell called iPS cells. The reason we are excited is because iPS cells have almost all the same properties as embryonic stem cells, but are not made from an embryo. Thus, there are no ethical concerns with iPS cells. In addition, iPS cells are made from a patients own non-stem cells, meaning that iPS cells could be given back to a patient without risk of immune rejection, an important issue with any stem cell transplant.
What does the future hold and how could stem cells change how your doctor treats you?
Because by nature stem cells have the job of replacing sick or old cells, scientists have conceived the idea of using stem cells as therapies for patients with a wide variety of medical conditions. The idea here is that by giving a sick patient stem cells or differentiated cells made from stem cells, we can make use of the stem cells natural ability to heal to make the patient healthy again. For example, if a patient has a heart attack, by giving that patient a transplant of stem cells as a therapy our goal is to have the transplanted stem cells repair the damage to the heart. The natural populations of stem cells that we all possess have only a limited capacity to fix injuries to our bodies. Going back to the example of the heart, the hearts own stem cells are just not up to the task of fixing the damage from a heart attack, but a transplant of millions of stem cells would be far more powerful. Therefore by giving patients transplants of stem cells we boost the bodys ability to heal beyond the capabilities of the limited number of naturally occurring stem cells. Some challenges remain to be addressed before stem cell therapies become more common including safety, as stem cells can potentially form tumors, and immune rejection. Even so, stem cells are likely to transform medicine and in perhaps just one or two decades most of us will know someone, perhaps even ourselves, who has had a stem cell transplant. Stem cells hold promise to treat most of the major diseases that people face including cancer, heart disease, Parkinsons Disease, Multiple Sclerosis, Stroke, Huntingtons Disease, spinal cord injury, and many more.
What stem cell treatments are available now and why most doctors recommend that you should only consider those with caution and as a last resort?
Currently, there are few stem cell transplants available that are proven by scientists to be both safe and effective. The best example is bone marrow transplantation. However, many unproven stem cell treatments are being advertised and offered around the world. Often these treatments get a lot of attention in the media, frequently when celebrities such as sports stars get these treatments. Generally, scientists and doctors in the stem cell field caution patients against such treatments because it is unclear whether these treatments actually work and whether they are safe. Patients have died from such treatments. While it is reasonable to consider all options when facing a potentially incurable condition or disease, we recommend that you only consider such treatments as a last resort and only after talking with your personal physician.
By Paul Knoepfler
Note that you may also find this Closer Look at Stem Cells resource page very helpful.
See the rest here:
- Induced Pluripotent Stem Cells Market to Grow with an Impressive CAGR - Farming Sector - January 8th, 2021
- Exacis Biotherapeutics Announces Its Launch and mRNA Technology In-Licensing For Targeted CAR-NK And CAR-T Cell Cancer Therapies | DNA RNA and Cells |... - January 8th, 2021
- Spinogenix Wins Grant to Advance Testing of Potential Oral Therapy - ALS News Today - January 8th, 2021
- The Cell Banking Outsourcing Market to trample recession in the next 10 years - Farming Sector - December 30th, 2020
- Global Induced Pluripotent Stem Cells (iPSCs) Market 2020 ... - December 20th, 2020
- Do You Know the 5 Types of Stem Cells? | BioInformant - December 20th, 2020
- Where do stem cells come from? Expert answers - The Niche - December 18th, 2020
- Induction of pluripotent stem cells from mouse embryonic ... - December 18th, 2020
- Top Technical Advances of 2020 - The Scientist - December 18th, 2020
- Network of Genes Involved in Congenital Heart Disease Identified - Technology Networks - December 17th, 2020
- Epigenetic Changes Implicated in Age-related Diminution in Vision and Its Possible Reversal - JD Supra - December 17th, 2020
- The Promise of Using Cell Cultures To Fight SARS-CoV-2 - Technology Networks - December 17th, 2020
- Global Induced Pluripotent Market 2020-26 Steering Forces Heading Towards Impressive CAGR With CELGENE CORPORATION; Astellas Pharma Inc.; Thermo... - December 17th, 2020
- Fate Therapeutics Reports Positive Interim Data from its Phase 1 Study of FT516 in Combination with Rituximab for B-cell Lymphoma | DNA RNA and Cells... - December 7th, 2020
- Fate Therapeutics (FATE) Reports Positive Interim Data from its Phase 1 Study of FT516 in Combination with Rituximab for B-cell Lymphoma -... - December 7th, 2020
- Researchers restore lost sight in mice, offering clues to reversing aging - Science Magazine - December 7th, 2020
- Bayer and Atara Biotherapeutics in CAR T-cell therapy deal - BioPharma-Reporter.com - December 7th, 2020
- Multiple sclerosis iPS-derived oligodendroglia conserve their properties to functionally interact with axons and glia in vivo - Science Advances - December 6th, 2020
- Repairing the Brain With Stem Cells? A Conversation With Prof. Jack Price - Being Patient - December 3rd, 2020
- Global Induced Pluripotent Stem Cells Market Size, Comprehensive Analysis, Development Strategy, Future Plans and Industry Growth with High CAGR by... - December 3rd, 2020
- Bayer Launches Cell and Gene Therapy Platform to Maximize Recent Acquisitions - PharmaLive - December 3rd, 2020
- Industry Verticals: Induced Pluripotent Stem Cells (iPSC) Market Latest and updated Scope and Application 2020-2027 - The Blend - December 3rd, 2020
- Fate Therapeutics to Host Virtual Event at the 2020 ASH Annual Meeting - StreetInsider.com - December 3rd, 2020
- Stem Cells Market Detailed Analysis by On-going Trends, Prominent Size, Share, Sales and Forecast to 2025 - PRnews Leader - November 18th, 2020
- Coadministration of endothelial and smooth muscle cells derived from human induced pluripotent stem cells as a therapy for critical limb ischemia -... - November 14th, 2020
- The Induced Pluripotent Stem Cells Market To Witness Fierce Competition Amongst The Key Players - KYT24 - November 14th, 2020
- Induced Pluripotent Stem Cells (iPSCs) Market Size, Drivers, Potential Growth Opportunities, Competitive Landscape, Trends And Forecast To 2027 -... - November 14th, 2020
- Proteintech and HebeCell Announce Collaboration on Nanobody iPSC-derived Natural Killer Cells - BioSpace - November 14th, 2020
- Neurons stripped of their identity are hallmark of Alzheimers disease, study finds - Newswise - November 14th, 2020
- Genetic influences on viral-induced cytokine responses in the lung - DocWire News - November 14th, 2020
- Stem Cell Manufacturing Market Share & Size, Future Growth, Trends Evaluation, Demands, Regional Analysis and Forecast to 2027| Merck Group,... - November 14th, 2020
- Global Induced Pluripotent Stem Cells Market Analysis Trends, Growth Opportunities, Size, Type, Dynamic Demand and Drives with Forecast to 2026 -... - November 10th, 2020
- StemBioSys and Cartox Announce Publication of Research Demonstrating CELLvo Matrix Plus Significantly Enhances the Functionality of hiPSC... - November 10th, 2020
- Induced Pluripotent Stem Cells Market Comprehensive Insights, Growth, Forecast and Covid-19 Impact by 2026 | Medipost Co. Ltd., Ocata Therapeutics... - November 10th, 2020
- Epoxy Resins Market to See a Major Financial Boost in the Forecast Duration Of 2020 To 2027 - TechnoWeekly - November 10th, 2020
- Advancement in technology foreseen to drive the global Induced Pluripotent Stem Cells Market during 2020 to 2026 - Stock Market Vista - November 6th, 2020
- Generation of normal induced pluripotent stem cell line KUMCi002-A from bone marrow CD34+ cells of patient with multiple myeloma disease having 13q... - November 6th, 2020
- Freezing Solutions for Clinical Application of Cell Therapy Products - Genetic Engineering & Biotechnology News - November 6th, 2020
- Global Induced Pluripotent Market Business Share, Industry Size and Future Investment Opportunities by 2026||Bristol-Myers Squibb Company; CELGENE... - November 6th, 2020
- Fate Therapeutics Reports Third Quarter 2020 Financial Results and Highlights Operational Progress - StreetInsider.com - November 6th, 2020
- Fate Therapeutics Announces Twelve Presentations at the 2020 ASH Annual Meeting - GlobeNewswire - November 6th, 2020
- The Stem Cell-Derived Cells market to be in conjunction to growth from 2020 to 2030 - PRnews Leader - October 31st, 2020
- Induced Pluripotent Stem Cells (iPSCs) Market 2019 | How The Industry Will Witness Substantial Growth In The Upcoming Years | Exclusive Report By... - October 29th, 2020
- The Induced Pluripotent Stem Cells Market To Witness A Major Breakthrough In The Form Of A Double-Digit CAGR Of 7% - KYT24 - October 29th, 2020
- Emulate Signs Collaborative Agreement with the FDA to Apply Lung-Chip to Evaluate Safety of COVID-19 Vaccines and Protective Immunity Against... - October 29th, 2020
- QurAlis Announces Appointment of New Chief Medical Officer and Formation of Clinical Advisory Board - BioSpace - October 29th, 2020
- SFARI | New collaboration between SFARI and Nancy Lurie Marks Family Foundation will generate hundreds of iPSC lines for autism research - SFARI News - October 24th, 2020
- Kobe Hospital Trials Transplant to Reverse Blindness A First in the World - JAPAN Forward - October 24th, 2020
- Global Induced Pluripotent Stem Cells (iPSCs) Market 2020 Potential Growth, Competitive Landscape and Development of Industry by 2025 Wall Street... - October 20th, 2020
- Induced Pluripotent Stem Cells Market To Grow At 7% YOY In Forecast Years 2026 - The Think Curiouser - October 20th, 2020
- Groundbreaking eye surgery in Kobe offers hope to sight impaired : The Asahi Shimbun - Asahi Shimbun - October 20th, 2020
- AMSBIO Launches New Human iPSC-Derived Cells and iPSC Differentiation Reagent Kits - Technology Networks - October 20th, 2020
- Global Stem Cell Manufacturing Market: Industry Analysis and forecast 2019 2027: By Product, Application, End-Users and Region - Stock Market Vista - October 20th, 2020
- Induced Pluripotent Stem Cells Market 2020 Is Slated to Grow Rapidly in the Forthcoming Years with Key Players Addgene, Axol Bioscience, Cell... - October 17th, 2020
- Global Stem Cell Therapy Market 2020: Trends, and Opportunity Analysis, Top Manufacturers And Forecast to 2027 - PRnews Leader - October 17th, 2020
- Disruptive Technologies and Mature Regulatory Environment Vital for Cell Therapy Maturation - BioSpace - October 17th, 2020
- Fate Therapeutics Announces Presentations at the 2020 Society for Immunotherapy of Cancer Annual Meeting - GlobeNewswire - October 17th, 2020
- Regeneron, Trump, and the alleged hypocrisy of the pro-life movement - Christian Post - October 17th, 2020
- Manufacturing a Personalized Cellular Universe: 3D Bioprinting in the Biotech Industry - BioSpace - October 17th, 2020
- SGEN: The 3 Top Biotech Stocks That Hedge Fund Managers LOVE - StockNews.com - October 10th, 2020
- Preclinical Study Shows Improvement In Recovery From Heart Attack With Exosomes - Anti Aging News - October 10th, 2020
- Was the antibody cocktail used to treat President Trump developed using human embryonic stem cells? - CBS News 8 - October 10th, 2020
- Cytovia Therapeutics partners with Inserm to develop selective CD38 NK therapeutics and offer new treatment options for Multiple Myeloma patients |... - October 10th, 2020
- iPS Cells: The STEM of the Future - Careers with STEM - October 8th, 2020
- Shinya Yamanaka - Wikipedia - October 8th, 2020
- Patient Genotyping: Potential Key to Treating Alzheimer's - ubmd.com - October 8th, 2020
- Global Induced Pluripotent Stem Cells (iPSCs) Market To Witness The Highest Growth Globally In Coming Years || Bristol-Myers Squibb Company, ViaCyte,... - October 5th, 2020
- Huge Investment in Induced Pluripotent Stem Cells Market Expected to Witness the Highest Growth 2026 | Fujifilm Holding Corporation (CDI) Ncardia,... - October 4th, 2020
- Recording thousands of nerve cell impulses at high resolution - Newswise - October 4th, 2020
- Stem Cell-Derived Cells Market Forecasted To Surpass The Value Of US$ XX Mn/Bn By 2019 - 2029 - Stock Market Funda - October 4th, 2020
- Cell and Gene Therapy Technology Update: ReNeuron Presents Positive Data | Roots Analysis - Crypto Daily - October 2nd, 2020
- Measuring chips amplify and record nerve cells - Futurity: Research News - October 2nd, 2020
- Kyoto University project aims to supply iPS cells widely at low cost - The Japan Times - September 29th, 2020
- The new pharma collaborations driving transformative research in oncology - - pharmaphorum - September 29th, 2020
- The Male Y Chromosome Does More Than We Thought - Lab Manager Magazine - September 29th, 2020
- Cytovia Therapeutics to present at Jefferies Cell Therapy Virtual Summit, BIO Investor Forum and New York Stem Cell Foundation Conference in October... - September 29th, 2020
- funded study sheds light on abnormal neural function in rare genetic disorder - National Institutes of Health - September 29th, 2020
- Global Induced Pluripotent Stem Cells (iPSCs) Market 2020 Manufacturer Analysis, Technology Advancements, Industry Scope and Forecast to 2027||Fate... - September 22nd, 2020
- Hair Regeneration Therapy Company Stemson Therapeutics Raises $7.5 Million - Pulse 2.0 - September 22nd, 2020
- Heart tissue regeneration: a "cell-less" therapy may be the key - Emergency-Live - September 18th, 2020